Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis. Lin Y C, Winokur P, Blake A, Wu T, Romm E, Bielekova B Ann Clin Transl Neurol. 2015 May; 2(5):445-55. Epub 2015 Apr 07. PMID: 26000318. Abstract CommentRecommendBookmarkWatch
